References
- Kushner J P, Lee G R, Wintrobe M M, Cartwright G E. Idiopathic refractory sideroblastic anemia: clinical and laboratory investigation of 17 patients and review of the literature. Medicine 1971; 50: 139–59
- Juneja S K, Imbert M, Jouault H, Scoazec J Y, Sigaux F, Sultan C. Haematological features of primary myelodys‐plastic syndromes (PMDS) at initial presentation: a study of 118 cases. J Clin Pathol 1983; 36: 1129–35
- Cheng D S, Kushner J P, Wintrobe M M. Idiopathic refractory sideroblastic anemia: incidence and risk factors for leukemic transformation. Cancer 1979; 44: 724–31
- Cazzola M, Barosi G, Gobbi P G, Invemizzi R, Riccardi A, Ascari E. Natural history of idiopathic refractory sideroblastic anemia. Blood 1988; 71: 305–12
- Garand R, Gardais J, Bizet M, Bremond J L, Accard F, Callat M P, de Bouchony E T, Goasguen J E. Heterogeneity of acquired idiopathic sideroblastic anaemia (AISA). Leuk Res 1992; 16: 463–8
- Neuwirtova R, Mocikova K, Musilova J, Jelinek J, Havlicek F, Michalova K, Adamkov M. Mixed myelodysplastic and myeloproliferative syndromes. Leuk Res 1996; 20: 717–26
- Dewald G W, Davis M P, Pierre R V, O'Fallon J R, Hoagland H C. Clinical characteristics and prognosis of 50 patients with a myeloproliferative syndrome and deletion of part of the long arm of chromosome 5. Blood 1985; 66: 189–97
- Goasguen J E, Garand R, Bizet M, Bremond J L, Gardais J, Callat M P, Accard F, Chaperon J. Prognostic factors of myelodysplastic syndromes ‐ a simplified 3‐ scoring system. Leuk Res 1990; 14: 255–62
- Streeter R R, Presant C A, Reinhard E. Prognostic significance of thrombocytosis in idiopathic sideroblastic anemia. Blood 1977; 50: 427–32